Hoth Therapeutics, Inc.

HOTH · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$8,188-$8,106-$11,372-$14,314
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$804$216$621$1,323
Change in WC$405-$487$594$530
Other Non-Cash$1-$70$859$371
Operating Cash Flow-$6,978-$8,447-$9,298-$12,090
Investing Activities
PP&E Inv.$0$0-$74-$117
Net Acquisitions$0$0$0$117
Inv. Purchases$0$0$0-$2,556
Inv. Sales/Matur.$0$0$1,236$2,508
Other Inv. Act.$0$0$0-$117
Investing Cash Flow$0$0$1,162-$165
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$1,061$11,315$5,985$17,835
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$3,682$2$51$360
Financing Cash Flow$4,743$11,317$6,036$18,195
Forex Effect-$18-$7-$10-$31
Net Chg. in Cash-$2,253$2,864-$2,110$5,909
Supplemental Information
Beg. Cash$9,292$6,429$8,538$2,630
End Cash$7,039$9,292$6,429$8,538
Free Cash Flow-$6,978-$8,447-$9,372-$12,207